Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M60.8Revenue $M47.8Net Margin (%)-82.8Z-Score-7.8
Enterprise Value $M80.2EPS $-2.4Operating Margin %3.7F-Score2
P/E(ttm))0Cash Flow Per Share $-4.3Pre-tax Margin (%)-82.8Higher ROA y-yY
Price/Book010-y EBITDA Growth Rate %0Quick Ratio4.9Cash flow > EarningsN
Price/Sales8.15-y EBITDA Growth Rate %0Current Ratio5.3Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-84.2Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M17.3ROI % (ttm)-871.7Gross Margin Increase y-yN

Gurus Latest Trades with ALXA

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

ALXA is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


ALXA: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
RINGOLD GORDONDirector 2013-09-06Buy10,000$4.77-26.62 view
KING THOMAS BRAXTONPres & CEO 2013-07-26Buy40,000$4.48-21.88 view
KING THOMAS BRAXTONPres & CEO 2013-07-26Buy40,000$4.48-21.88 view
LANSDOWNE PARTNERS AUSTRIA GMB10% Owner 2013-01-18Sell125,000$4.75-26.32 view
LANSDOWNE PARTNERS AUSTRIA GMB10% Owner 2012-12-27Buy72,189$4.85-27.84 view
Simms Michael JSVP, Operations & Manuf 2012-12-26Sell4,558$4.9-28.57 view
Cassella James VEVP, R&D and CSO 2012-12-26Sell4,558$4.9-28.57 view
Cassella James VEVP, R&D and CSO 2012-08-27Sell10,000$4.14-15.46 view
KING THOMAS BRAXTONPres & CEO 2012-08-27Sell10,000$4.14-15.46 view
Moreland DarlSVP, Quality 2012-08-27Sell10,000$4.14-15.46 view

Press Releases about ALXA :

    Quarterly/Annual Reports about ALXA:

    News about ALXA:

    Articles On GuruFocus.com
    Wrong Marketing Lesson by Big Pharma May 03 2014 
    Weekly CEO Buys Highlight: RCL, PSXP, ALXA, PAY, HAFC Aug 05 2013 
    Royal Caribbean and Four Others Report $100 Thousand CEO Buys Jul 31 2013 
    President and CEO of Alexza Pharmaceuticals Inc. Thomas Braxton King Bought 40,000 Shares Jul 29 2013 
    Weekly CEO Buys Highlight: NYLD, ALXA, DOC, NTWK, SNV Jul 29 2013 
    Alexza Pharmaceuticals Inc. (ALXA) SVP, CFO & Sec August J Moretti sells 10,000 Shares May 07 2010 
    cooldecency99 note on ALXA May 01 2010 
    Alexza Pharmaceuticals Inc. (ALXA) SVP, CFO & Sec August J Moretti sells 14,000 Shares Dec 21 2009 
    Alexza Pharmaceuticals Inc. (ALXA) Pres & CEO Thomas Braxton King sells 45,000 Shares Dec 21 2009 
    Weekly CEO Buy Highlight: Winmark Corp, Alexza Pharmaceuticals Inc, Ladenburg Thalmann Financial Ser Oct 11 2009 

    More From Other Websites
    ALEXZA PHARMACEUTICALS INC. Financials Aug 19 2014
    Alexza Pharmaceuticals Provides an Update on the Five Post-EMA Approval Studies for ADASUVE® Aug 14 2014
    Alexza Pharmaceuticals Announces the Launch of ADASUVE® (inhalation powder, loxapine) in Guatemala Aug 08 2014
    Alexza Pharmaceuticals Inc Earnings Call scheduled for 5:00 pm ET today Aug 07 2014
    ALEXZA PHARMACEUTICALS INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Aug 07 2014
    Alexza Reports 2014 Second Quarter Financial Results Aug 07 2014
    Q2 2014 Alexza Pharmaceuticals, Inc. Earnings Release - After Market Close Aug 07 2014
    ALEXZA PHARMACEUTICALS INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jul 31 2014
    Alexza Provides Pipeline Update Jul 31 2014
    Alexza Pharmaceuticals Announces Participation in Upcoming Investor Conferences Jul 29 2014
    Alexza to Report 2014 Second Quarter Financial Results on Thursday, August 7, 2014 Jul 17 2014
    ALEXZA PHARMACEUTICALS INC. Files SEC form 8-K, Change in Directors or Principal Officers Jul 08 2014
    ALEXZA PHARMACEUTICALS INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Jun 30 2014
    Alexza Announces the Promotion of Edwin S. Kamemoto, Ph.D. to Senior Vice President, Regulatory... Jun 30 2014
    ALEXZA PHARMACEUTICALS INC. Files SEC form 8-K, Creation of a Direct Financial Obligation or an... Jun 16 2014
    ALEXZA PHARMACEUTICALS INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jun 11 2014
    Teva launching 3 drugs in 2014 with combined peak sales of $1 bln May 20 2014
    Morgan Stanley reports 5.0% passive stake in Alexza Pharmaceuticals May 16 2014
    Alexza Pharmaceuticals management to meet with Roth Capital May 09 2014
    Alexza Pharmaceuticals' (ALXA) CEO Tom King on Q1 2014 Results - Earnings Call Transcript May 05 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK